Cargando…

P12 Commissioning for Quality and Innovation (CQUIN) schemes—revisiting urinary tract infection (UTI) management. What worked? What lasted? What next?

BACKGROUND: UK CQUIN schemes encourage an improvement focus on a specific area of care. In 2019, CQUIN CCG1a: Improving the management of lower UTI in older people(1) was adopted at the RUH resulting in increased alignment with UK guidance on diagnosis and treatment.(2) Our aim was to investigate wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Slatter, Mandy, Aprilia, Valentin, Boyd, Rebecca, Chan, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848849/
http://dx.doi.org/10.1093/jacamr/dlac133.016
_version_ 1784871805044916224
author Slatter, Mandy
Aprilia, Valentin
Boyd, Rebecca
Chan, Teresa
author_facet Slatter, Mandy
Aprilia, Valentin
Boyd, Rebecca
Chan, Teresa
author_sort Slatter, Mandy
collection PubMed
description BACKGROUND: UK CQUIN schemes encourage an improvement focus on a specific area of care. In 2019, CQUIN CCG1a: Improving the management of lower UTI in older people(1) was adopted at the RUH resulting in increased alignment with UK guidance on diagnosis and treatment.(2) Our aim was to investigate whether this improvement was sustained two years later. This would help inform quality improvement interventions prior to adoption of the 2022 CQUIN, CCG2: Appropriate antibiotic prescribing for UTI in adults aged 16+.(3) OBJECTIVES: Service evaluation of the UTI pathway including compliance with two of the CQUIN care processes for UTI diagnosis in patients age 65+ presenting to ED (not admitted): (i) diagnosis excludes use of urine dipstick in people aged 65+; and (ii) urine sample sent to microbiology as per UK guidance.(2) METHODS: A search of the electronic patient record for key terms (Table 1) identified 6076 ED attendances for patients age 65+ between 1 August and 31 October 2021 of which 40 were identified with a primary diagnosis of UTI not requiring hospital admission. Paramedic, ED and Urgent Treatment Centre notes (paper and electronic) were reviewed in detail and information gathered regarding presence/absence of UTI symptoms aligned to diagnostic guidelines;(2) presence/absence of urine dipstick test; and presence/absence of urine sample for culture and susceptibility testing. Findings were compared with identical trust data for patients (admitted and non-admitted) obtained during the 2019 CQUIN: Q1 April–June; Q2 July–September; Q3 October–December. During this period improvement interventions were implemented. RESULTS: See Table 2. CONCLUSIONS: Following intensive staff education improved practice regarding urine dipstick testing and appropriate urine sampling in elderly patients with possible UTI was observed during the 2019 CQUIN period. Two years later this improvement had not been sustained. When planning interventions during the 2022 CQUIN,(3) consideration should be given to a bundle of interventions including education, data feedback and systems improvement, for example, computerized decision support systems (CDSS) to embed sustained change. [Table: see text] [Table: see text]
format Online
Article
Text
id pubmed-9848849
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-98488492023-01-21 P12 Commissioning for Quality and Innovation (CQUIN) schemes—revisiting urinary tract infection (UTI) management. What worked? What lasted? What next? Slatter, Mandy Aprilia, Valentin Boyd, Rebecca Chan, Teresa JAC Antimicrob Resist Abstracts BACKGROUND: UK CQUIN schemes encourage an improvement focus on a specific area of care. In 2019, CQUIN CCG1a: Improving the management of lower UTI in older people(1) was adopted at the RUH resulting in increased alignment with UK guidance on diagnosis and treatment.(2) Our aim was to investigate whether this improvement was sustained two years later. This would help inform quality improvement interventions prior to adoption of the 2022 CQUIN, CCG2: Appropriate antibiotic prescribing for UTI in adults aged 16+.(3) OBJECTIVES: Service evaluation of the UTI pathway including compliance with two of the CQUIN care processes for UTI diagnosis in patients age 65+ presenting to ED (not admitted): (i) diagnosis excludes use of urine dipstick in people aged 65+; and (ii) urine sample sent to microbiology as per UK guidance.(2) METHODS: A search of the electronic patient record for key terms (Table 1) identified 6076 ED attendances for patients age 65+ between 1 August and 31 October 2021 of which 40 were identified with a primary diagnosis of UTI not requiring hospital admission. Paramedic, ED and Urgent Treatment Centre notes (paper and electronic) were reviewed in detail and information gathered regarding presence/absence of UTI symptoms aligned to diagnostic guidelines;(2) presence/absence of urine dipstick test; and presence/absence of urine sample for culture and susceptibility testing. Findings were compared with identical trust data for patients (admitted and non-admitted) obtained during the 2019 CQUIN: Q1 April–June; Q2 July–September; Q3 October–December. During this period improvement interventions were implemented. RESULTS: See Table 2. CONCLUSIONS: Following intensive staff education improved practice regarding urine dipstick testing and appropriate urine sampling in elderly patients with possible UTI was observed during the 2019 CQUIN period. Two years later this improvement had not been sustained. When planning interventions during the 2022 CQUIN,(3) consideration should be given to a bundle of interventions including education, data feedback and systems improvement, for example, computerized decision support systems (CDSS) to embed sustained change. [Table: see text] [Table: see text] Oxford University Press 2023-01-19 /pmc/articles/PMC9848849/ http://dx.doi.org/10.1093/jacamr/dlac133.016 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Slatter, Mandy
Aprilia, Valentin
Boyd, Rebecca
Chan, Teresa
P12 Commissioning for Quality and Innovation (CQUIN) schemes—revisiting urinary tract infection (UTI) management. What worked? What lasted? What next?
title P12 Commissioning for Quality and Innovation (CQUIN) schemes—revisiting urinary tract infection (UTI) management. What worked? What lasted? What next?
title_full P12 Commissioning for Quality and Innovation (CQUIN) schemes—revisiting urinary tract infection (UTI) management. What worked? What lasted? What next?
title_fullStr P12 Commissioning for Quality and Innovation (CQUIN) schemes—revisiting urinary tract infection (UTI) management. What worked? What lasted? What next?
title_full_unstemmed P12 Commissioning for Quality and Innovation (CQUIN) schemes—revisiting urinary tract infection (UTI) management. What worked? What lasted? What next?
title_short P12 Commissioning for Quality and Innovation (CQUIN) schemes—revisiting urinary tract infection (UTI) management. What worked? What lasted? What next?
title_sort p12 commissioning for quality and innovation (cquin) schemes—revisiting urinary tract infection (uti) management. what worked? what lasted? what next?
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848849/
http://dx.doi.org/10.1093/jacamr/dlac133.016
work_keys_str_mv AT slattermandy p12commissioningforqualityandinnovationcquinschemesrevisitingurinarytractinfectionutimanagementwhatworkedwhatlastedwhatnext
AT apriliavalentin p12commissioningforqualityandinnovationcquinschemesrevisitingurinarytractinfectionutimanagementwhatworkedwhatlastedwhatnext
AT boydrebecca p12commissioningforqualityandinnovationcquinschemesrevisitingurinarytractinfectionutimanagementwhatworkedwhatlastedwhatnext
AT chanteresa p12commissioningforqualityandinnovationcquinschemesrevisitingurinarytractinfectionutimanagementwhatworkedwhatlastedwhatnext